GULF RESOURCES, INC. 8-K

What Happened

• Gulf Resources, Inc. (GURE) announced the closing of a previously disclosed sale: on December 22, 2025, the industrial and commercial registration authority (AMR) recorded Shandong Rongyuan Pharmaceutical Co., Ltd. as the sole shareholder of Shouguang Yuxin Chemical Industry Co., Limited, completing the sale of 100% equity in that Target Company.
• The sale was made under a Share Purchase Agreement (SPA) dated December 10, 2025 between the Seller (Shouguang City Haoyuan Chemical Co. Ltd., an indirect wholly owned subsidiary of Gulf Resources), the Purchaser (Shandong Rongyuan Pharmaceutical) and the Target Company. The Company has incorporated its audited financials (year ended Dec 31, 2024) and interim results (nine months ended Sep 30, 2025) by reference and filed unaudited pro forma condensed combined financial statements.

Key Details

• Transaction closing date: December 22, 2025 (registration by AMR completed).
• Asset sold: 100% equity interest in Shouguang Yuxin Chemical Industry Co., Ltd.
• SPA date: December 10, 2025; Purchaser: Shandong Rongyuan Pharmaceutical Co., Ltd.; Seller: Shouguang City Haoyuan Chemical Co., Ltd.
• Company filed unaudited pro forma condensed combined financial statements (Exhibit 99.1) reflecting the transaction as of Dec 31, 2024 and Sep 30, 2025; core financial statements for those periods are incorporated by reference.

Why It Matters

• For investors, the closing means Gulf Resources has divested a China-based operating entity, which can affect future revenue, earnings and asset composition. The company filed pro forma financials so investors can see what the company's historical results would look like after the disposition.
• The 8-K does not disclose purchase price or detailed economic terms in this filing; investors should review the pro forma statements and Gulf Resources’ Form 10-K/10-Q filings for more context and any disclosed risks. The company also reiterated standard forward-looking statement disclaimers and referenced prior SEC filings for risk factors.